Last reviewed · How we verify

NCT05396053

Mirror Therapy Versus CIMT on Hand Function in Cerebral Palsy

Completed NA Last updated 9 January 2024
What this trial tests

NA trial testing Physical therapy exercises in Hemiplegic Cerebral Palsy in 74 participants. Completed in 10 October 2022.

Timeline
26 May 2022
Primary endpoint
15 August 2022
10 October 2022

Quick facts

Lead sponsorBatterjee Medical College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment74
Start date26 May 2022
Primary completion15 August 2022
Estimated completion10 October 2022
Sites2 locations across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Batterjee Medical College

Who can join

Adults 5 to 9, any sex, with Hemiplegic Cerebral Palsy or Mirror Hands. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to investigate the effect of mirror therapy on hand functions in children with hemiplegic cerebral palsy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Enhancing Grip Strength and Manual Dexterity in Unilateral Cerebral Palsy: A Randomized Trial of Mirror Visual Feedback vs. Modified Constraint-Induced Movement Therapy.
    Abdel Ghafar MA, Abdelraouf OR, Alkhamees NH, Mohamed ME, et al · · 2025 · cited 2× · PMID 40149826 · DOI 10.3390/brainsci15030305

Verify or expand the search:

Other trials of Physical therapy exercises

Trials testing the same drug.

Other recruiting trials for Hemiplegic Cerebral Palsy

Currently open trials in the same condition.

Other Batterjee Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05396053.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing